Fresh & Easy opens in South L.A.
SOUTH LOS ANGELES, Calif. Fresh & Easy has opened its first store in South Los Angeles.
According to the company, the store was one of the first sites identified by the grocer over two years ago and is the centerpiece of an impressive new mixed-use development with affordable housing units and additional retail space.
Mary Kasper, VP and general counsel for Fresh & Easy Neighborhood Market, said, “We’re opening stores in all types of neighborhoods because we fundamentally believe everyone regardless of where they live deserves access to quality, fresh food at affordable prices. We’re also proud to bring more quality jobs to the neighborhood, particularly in this economy.”
Dollar General CEO delivers keynote address at RILA conference
ORLANDO, Fla. The Retail Industry Leaders Association’s 2010 Logistics Conference kicked off Monday with a keynote address delivered by Dollar General chairman and CEO Rick Dreiling.
Dreiling shared his perspective with attendees on the crucial role of the supply chain in retail operations today as customers, employees, investors and suppliers are coping with the uncertainty of a strained economy and legislative and regulatory overhauls, RILA said. Dreiling, who joined Dollar General in January 2008 as CEO and was named chairman of the board in December 2008, spearheaded the company’s reemergence as a public company through a successful initial public offering on the New York Stock Exchange on Nov. 13, 2009.
“Rick Dreiling opened the day with a compelling dialogue and inside look at the substantial impact and competitive edge that strategic investments and process improvements in supply chain can have for retailers in this challenging economic climate,” said RILA president Sandy Kennedy.
RILA’s 2010 Logistics Conference is being held at the Gaylord Palms Resort & Convention Center in Orlando, Fla.
Combined HIV drug therapy may cause heart rhythm issues
ROCKVILLE, Md. Combining two HIV drugs made by Roche subsidiary Genentech and Abbott could cause abnormalities in patients’ heart rhythms, the Food and Drug Administration said Tuesday.
The FDA announced preliminary data suggesting that combining Roche’s Invirase (saquinavir) and Abbott’s Norvir (ritonavir) could prolong the heart’s QT and PR intervals. Prolongation of the QT interval can lead to a condition known as torsades de pointes, an abnormal heart rhythm, while a prolonged PR interval can lead to heart block, also an abnormal heart rhythm. Both conditions can cause lightheadedness, fainting or abnormal heart beats. In some cases, torsades de pointes can progress to ventricular fibrillation, a potentially fatal irregular heartbeat.
The FDA said review of the data was ongoing.